Home » Offshore Buyer Has Sigma Pharmaceuticals in Its Sights
Offshore Buyer Has Sigma Pharmaceuticals in Its Sights
South Africa’s Aspen Pharma has made an opportunistic bid for the troubled Sigma Pharmaceuticals, which has suffered a 60 per cent plunge in the value of its shares since reporting a $389 million loss.
The Australian
The Australian
Upcoming Events
-
07May
-
14May
-
30May